Tarsus Pharmaceuticals, Inc. (TARS): Shares Outstanding

Annual figures by period end, from SEC filings.

42.55M
As of 2025-12-31
43.27M
As of 2026-06-30
+16.8%
3-year compound annual growth
+15.9%
5-year compound annual growth
2019-12-31: 2.65M2020-12-31: 20.32M2021-12-31: 20.70M2022-12-31: 26.70M2023-12-31: 34.21M2024-12-31: 38.35M2025-12-31: 42.55M42.55M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3142.55M+11.0%2026-02-23, Balance as of period end
2024-12-3138.35M+12.1%2026-02-23, Balance as of period end
2023-12-3134.21M+28.1%2025-02-25, Balance as of period end
2022-12-3126.70M+29.0%2024-02-27, Balance as of period end
2021-12-3120.70M+1.8%2023-03-17, Balance as of period end
2020-12-3120.32M+667.9%2022-03-14, Balance as of period end
2019-12-312.65Mn/a2021-03-31, Balance as of period end